Seven days triple therapy for eradication of does not alter the disease activity of patients with inflammatory bowel disease

Seven days triple therapy for eradication of does not alter the disease activity of patients with inflammatory bowel disease

Background/Aims The influences of Helicobacter pylori eradication therapy on the disease course of inflammatory bowel disease (IBD) are still unclear. We therefore conducted a multicenter, retrospective cohort study to evaluate the safety of H. pylori eradication therapy for IBD patients. Methods IB...

Full description

Bibliographic Details
Main Authors: Shinichiro Shinzaki, Toshimitsu Fujii, Shigeki Bamba, Maiko Ogawa, Taku Kobayashi, Masahide Oshita, Hiroki Tanaka, Keiji Ozeki, Sakuma Takahashi, Hiroki Kitamoto, Kazuhito Kani, Sohachi Nanjo, Takeshi Sugaya, Yuko Sakakibara, Toshihiro Inokuchi, Kazuki Kakimoto, Akihiro Yamada, Hisae Yasuhara, Yoko Yokoyama, Takuya Yoshino, Akira Matsui, Misaki Nakamura, Taku Tomizawa, Ryosuke Sakemi, Noriko Kamata, Toshifumi Hibi
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2018-10-01
Series:Intestinal Research
Subjects:
eradication
Proton pump inhibitor
Clarithromycin
Metronidazole
Online Access:http://www.irjournal.org/upload/pdf/ir-2018-00044.pdf

Similar Items

Similar Items